相关实验视频

Updated: May 10, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

针对儿科上腺皮质癌:分子见解和新兴治疗策略

Michaela Kuhlen¹, Maximilian Schmutz², Marina Kunstreich³

¹Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany; Bavarian Cancer Research Center (BZKF), Augsburg, Germany.

Cancer treatment reviews

|April 21, 2025

概括

儿科上腺皮质癌 (pACC) 是一种罕见的儿童癌症,需要量身定制的治疗方法. 研究突出了分子标和新疗法,强调了合作,以获得更好的儿童结果.

科学领域:

儿科瘤学儿科瘤学
内分泌学在内分泌学.
癌症基因组学癌症基因组学

背景情况:

儿科上腺皮质癌 (pACC) 是一种罕见且侵袭性的儿童恶性瘤.
pACC具有独特的临床和分子特征,与成人ACC不同,通常与像Li-Fraumeni综合征这样的遗传综合征有关.
目前适应成人协议的治疗方法强调了对儿科特异性治疗策略的需求.

研究的目的:

审查当前对儿科上腺皮质癌 (pACC) 生物学和治疗景观的理解.
确定pACC的关键分子标和新兴的治疗途径.
强调儿科专用研究和临床试验的重要性.

主要方法:

对pACC临床表现,分子分析和治疗方法的当前文献的综述.
对了解pACC相关遗传综合征和分子通路的进展进行分析.
探索新的诊断和治疗策略,包括免疫疗法和代谢向.

主要成果:

分子分析揭示了pACC中的可操作目标,包括Wnt/β-catenin和MAP/ERK通路的改变,IGF2过度表达和表观遗传失调.
像免疫检查点抑制剂和CAR T细胞疗法这样的新兴疗法显示出希望,但需要小儿科的调查.
针对代谢漏洞和利用液体活检等先进诊断方法,为pACC管理提供了新的途径.

结论:

在将pACC研究转化为有效的儿科治疗中,仍然存在重大挑战.
专门针对儿童的临床试验和国际合作对于推进pACC护理至关重要.
个性化医疗方法,整合分子洞察力和新疗法,是改善pACC儿童治疗结果的关键.

关键词:

上皮层癌 (adrenocortical carcinoma) 是一种上皮层癌.儿童和青少年儿童和青少年概述概述概述概述概述治疗疗法治疗疗法

更多相关视频

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.